Montrusco Bolton Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-489,751
| Closed | -$133M | – | 59 |
|
|
2024
Q1 | $133M | Sell |
489,751
-232,340
| -32% | -$63M | 1.41% | 23 |
|
|
2023
Q4 | $167M | Sell |
722,091
-133,296
| -16% | -$30.9M | 2.08% | 20 |
|
|
2023
Q3 | $164M | Buy |
855,387
+225,562
| +36% | +$43.3M | 2.39% | 20 |
|
|
2023
Q2 | $131M | Buy |
629,825
+219,637
| +54% | +$45.5M | 2.02% | 22 |
|
|
2023
Q1 | $80.4M | Sell |
410,188
-33,658
| -8% | -$6.6M | 1.66% | 29 |
|
|
2022
Q4 | $94M | Buy |
443,846
+110,107
| +33% | +$23.3M | 2.18% | 20 |
|
|
2022
Q3 | $64.7M | Buy |
333,739
+31,078
| +10% | +$6.03M | 1.71% | 27 |
|
|
2022
Q2 | $63.9M | Sell |
302,661
-947
| -0.3% | -$200K | 1.7% | 28 |
|
|
2022
Q1 | $85.3M | Buy |
303,608
+136,231
| +81% | +$38.3M | 1.97% | 26 |
|
|
2021
Q4 | $62.1M | Buy |
167,377
+26,294
| +19% | +$9.75M | 1.46% | 30 |
|
|
2021
Q3 | $57.4M | Sell |
141,083
-89,487
| -39% | -$36.4M | 1.56% | 26 |
|
|
2021
Q2 | $84M | Sell |
230,570
-57,279
| -20% | -$20.9M | 2.52% | 15 |
|
|
2021
Q1 | $82.1M | Buy |
287,849
+50,486
| +21% | +$14.4M | 2.68% | 12 |
|
|
2020
Q4 | $57.8M | Buy |
+237,363
| New | +$57.8M | 2.54% | 12 |
|